Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Aditxt (ADTX)

Aditxt Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADTX
DateTimeSourceHeadlineSymbolCompany
18/07/202421:17Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ADTXAditxt Inc
18/07/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
17/07/202411:30Business WireAditxt and Evofem Amend and Restate Merger Agreement, Targeting September 30 ClosingNASDAQ:ADTXAditxt Inc
11/07/202421:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ADTXAditxt Inc
09/07/202422:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
08/07/202411:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
27/06/202413:36PR Newswire (US)Hello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's HealthcareNASDAQ:ADTXAditxt Inc
14/06/202421:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ADTXAditxt Inc
12/06/202421:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
07/06/202422:12Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:ADTXAditxt Inc
29/05/202421:33Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ADTXAditxt Inc
28/05/202411:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
22/05/202421:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
20/05/202421:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADTXAditxt Inc
15/05/202411:50PR Newswire (US)Evofem Biosciences Announces Financial Results for the First Quarter of 2024NASDAQ:ADTXAditxt Inc
13/05/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
08/05/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
07/05/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
03/05/202419:14Business WireCORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
03/05/202414:00Business WireAditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
02/04/202413:30Business WireAditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)NASDAQ:ADTXAditxt Inc
27/03/202412:36PR Newswire (US)Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023NASDAQ:ADTXAditxt Inc
11/03/202420:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
07/03/202412:54PR Newswire (US)For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended PregnancyNASDAQ:ADTXAditxt Inc
04/03/202422:27Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ADTXAditxt Inc
04/03/202422:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
01/03/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
29/02/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
22/02/202422:21Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ADTXAditxt Inc
21/02/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
 Showing the most relevant articles for your search:NASDAQ:ADTX